Respiratory News and Research

RSS

Free public grouper of medical condition episodes-of-care from CCGroup

CCGroup is pleased to announce the release today of a free download version of the Cave Grouper software known as CaveGrouper-Lite. This is the first public grouper of medical condition episodes-of-care.

7 Apr 2012

Sucampo announces positive results from lubiprostone phase 3 trial on OBD

Sucampo Pharmaceuticals, Inc. today announced positive top-line results from an open-label phase 3 clinical trial designed to evaluate the long-term safety and efficacy of lubiprostone in opioid-induced bowel dysfunction (OBD) patients with chronic, non-cancer-related pain.

6 Apr 2012

Cognitive and psychiatric impairments common among long-term ALI survivors

Cognitive and psychiatric impairments are common among long-term survivors of acute lung injury (ALI), and these impairments can be assessed using a telephone-based test battery, according to a new study.

6 Apr 2012

Collaborative Cross project to develop lab mice with increased genetic diversity

With a 95 percent genomic similarity to humans, mice have long been used to learn about the genetic causes of human disease. Once researchers can shine a light on the genetic factors that cause disease in mice, they can start to develop prevention and treatment options to protect the human population.

6 Apr 2012

Towards a drug to control cystic fibrosis

Harvard stem cell researchers at Massachusetts General Hospital (MGH) have taken a critical step in making possible the discovery in the relatively near future of a drug to control cystic fibrosis (CF), a fatal lung disease that claims about 500 lives each year, with 1,000 new cases diagnosed annually.

6 Apr 2012

Vaccination most promising against asthma

Asthma is a chronic inflammatory and respiratory disease caused by an abnormal reactivity to allergens in the environment. Of the several avenues of exploration that are currently being developed, vaccination appears to be the most promising approach.

5 Apr 2012

Early administration of corticosteroids reduces ED stay for children with asthma

Children with moderate or severe asthma attacks who are treated with systemic corticosteroids during the first 75 minutes of triage in the Emergency Department (ED) were 16% less likely to be admitted to hospital.

5 Apr 2012

Covidien to acquire Oridion Systems

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd.

5 Apr 2012

Asthma management tips for student athletes

For the student athlete with asthma, spring and summer pose particular dangers. The most significant danger is the all-too-frequent lack of access to a life-saving asthma inhaler, explains Maureen George, PhD, RN, of the University of Pennsylvania School of Nursing. Federal law permits students to carry their asthma inhalers with them, yet many schools do not because of safety concerns.

5 Apr 2012

Trends in diagnostic coding may explain the cause of decline in pneumonia hospitalizations

Although data indicate that between 2003-2009 there was a substantial decline in the U.S. in hospitalizations for pneumonia and inpatient deaths, analysis suggests that trends in documentation and diagnostic coding, rather than improvements in actual outcomes, may explain much of the observed changes, according to a study in the April 4 issue of JAMA.

4 Apr 2012

Post-operative complications after oesophageal cancer surgery may cause other health problems

Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet in Sweden shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for five years afterwards.

4 Apr 2012

Nurses empowered to administer oral steroids for asthma during emergency

Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics.

4 Apr 2012

Infections in older adults may increase risk of hospitalization for dangerous blood clots

Research shows older adults who get infections of any kind - such as urinary, skin, or respiratory tract infections - are nearly three times more likely to be hospitalized for a dangerous blood clot in their deep veins or lungs, University of Michigan Health System research shows.

4 Apr 2012

Combination of carboplatin, paclitaxel and RT3D shows promise against head and neck cancer

A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research.

4 Apr 2012

Novel tetracyclines with improved potency, efficacy against contemporary P. aeruginosa isolates

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

2 Apr 2012

ACAAI/AAAAI publish position statement in support of ATS guideline on Aerocrine's FeNO test

Aerocrine AB announces that a nine-member council representing both prestigious asthma societies, the American Academy and the American College of Allergy, Asthma and Immunology (ACAAI and AAAAI), have published a position statement in support of the clinical practice guideline on Aerocrine's FeNO test as published by the ATS.

2 Apr 2012

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

2 Apr 2012

ERS, ECDC publish European Union Standards for Tuberculosis Care

Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care.

2 Apr 2012

Cortex reports net income of $832,000 for fourth quarter 2011

Cortex Pharmaceuticals, Inc. reported net income of approximately $832,000, or $0.01 per share, for the quarter ended December 31, 2011, compared with a net loss of approximately $984,000, or $0.01 per share, for the corresponding prior year quarter.

31 Mar 2012

Data from Cempra's CEM-101 Phase 2 trial on CABP to be presented at ECCMID

Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.

31 Mar 2012

Respiratory News and Research

Free public grouper of medical condition episodes-of-care from CCGroup

Sucampo announces positive results from lubiprostone phase 3 trial on OBD

Cognitive and psychiatric impairments common among long-term ALI survivors

Collaborative Cross project to develop lab mice with increased genetic diversity

Towards a drug to control cystic fibrosis

Vaccination most promising against asthma

Early administration of corticosteroids reduces ED stay for children with asthma

Covidien to acquire Oridion Systems

Asthma management tips for student athletes

Trends in diagnostic coding may explain the cause of decline in pneumonia hospitalizations

Post-operative complications after oesophageal cancer surgery may cause other health problems

Nurses empowered to administer oral steroids for asthma during emergency

Infections in older adults may increase risk of hospitalization for dangerous blood clots

Combination of carboplatin, paclitaxel and RT3D shows promise against head and neck cancer

Novel tetracyclines with improved potency, efficacy against contemporary P. aeruginosa isolates

ACAAI/AAAAI publish position statement in support of ATS guideline on Aerocrine's FeNO test

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

ERS, ECDC publish European Union Standards for Tuberculosis Care

Cortex reports net income of $832,000 for fourth quarter 2011

Data from Cempra's CEM-101 Phase 2 trial on CABP to be presented at ECCMID

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News